Dr. Reddy's Laboratories
RDY
#1770
Rank
โ‚ฌ10.38 B
Marketcap
12,36ย โ‚ฌ
Share price
-1.22%
Change (1 day)
-3.55%
Change (1 year)

Revenue for Dr. Reddy's Laboratories (RDY)

Revenue in 2025 (TTM): โ‚ฌ3.43 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current revenue (TTM ) is โ‚ฌ3.34 Billion. a decrease over the revenue in the year 2024 that were of โ‚ฌ3.55 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Dr. Reddy's Laboratories from 2002 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ3.36 B-5.32%
2024 โ‚ฌ3.55 B19.8%
2023 โ‚ฌ2.96 B7.22%
2022 โ‚ฌ2.76 B12.04%
2021 โ‚ฌ2.47 B21.08%
2020 โ‚ฌ2.04 B-5.84%
2019 โ‚ฌ2.16 B14.73%
2018 โ‚ฌ1.88 B3.02%
2017 โ‚ฌ1.83 B-9.36%
2016 โ‚ฌ2.02 B-8.51%
2015 โ‚ฌ2.21 B14.28%
2014 โ‚ฌ1.93 B21.38%
2013 โ‚ฌ1.59 B10.12%
2012 โ‚ฌ1.44 B-0.14%
2011 โ‚ฌ1.44 B22.5%
2010 โ‚ฌ1.18 B10.8%
2009 โ‚ฌ1.06 B5.92%
2008 โ‚ฌ1.00 B15.2%
2007 โ‚ฌ0.87 B-7.25%
2006 โ‚ฌ0.94 B116%
2005 โ‚ฌ0.43 B34.6%
2004 โ‚ฌ0.32 B-3.5%
2003 โ‚ฌ0.33 B-3.98%
2002 โ‚ฌ0.35 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
โ‚ฌ47.99 B 1,332.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ53.16 B 1,487.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ40.24 B 1,101.52%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
โ‚ฌ35.86 B 970.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.61 B 336.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel